Gihad Nesrallah

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses

Reem A. Mustafa, Nancy Santesso, Jan Brożek et al. · Journal of Clinical Epidemiology · 2013 · 361 citations · Full text

Reliability, Method Validation, Engineering +8

Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study

Tahira Devji, Alonso Carrasco‐Labra, Anila Qasim et al. · BMJ · 2020 · 251 citations · Full text

Intensive Hemodialysis Associates with Improved Survival Compared with Conventional Hemodialysis

Gihad Nesrallah, Robert M. Lindsay, Meaghan S. Cuerden et al. · Journal of the American Society of Nephrology · 2012 · 214 citations

Hemodialysis, Intensive Hemodialysis Associates, Renal Function +15

Minutes to Recovery after a Hemodialysis Session

Robert M. Lindsay, Paul Heidenheim, Gihad Nesrallah et al. · Clinical Journal of the American Society of Nephrology · 2006 · 202 citations